Ali Round
Overview
Explore the profile of Ali Round including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dalziel K, Stein K, Round A, Garside R, Royle P
Am J Rhinol
. 2006 Oct;
20(5):506-19.
PMID: 17063747
Background: Functional endoscopic sinus surgery (FESS) has been used for >20 years for the management of sinus disease including the excision of nasal polyps. Our objective was to perform a...
2.
Stein K, Ratcliffe J, Round A, Milne R, Brazier J
Health Qual Life Outcomes
. 2006 Mar;
4:22.
PMID: 16571106
Background: The completeness of preferences is assumed as one of the axioms of expected utility theory but has been subject to little empirical study. Methods: Fifteen non-health professionals was recruited...
3.
Stein K, Fry A, Round A, Milne R, Brazier J
Appl Health Econ Health Policy
. 2006 Feb;
4(4):219-28.
PMID: 16466273
The objective of this article was to review the methods used to obtain quality-of-life (utility) weights reported in assessments carried out for the National Institute for Health and Clinical Excellence...
4.
Stein K, Dalziel K, Garside R, Castelnuovo E, Round A
Int J Technol Assess Health Care
. 2005 Aug;
21(3):277-87.
PMID: 16110706
Objectives: Case series constitute a weak form of evidence for effectiveness of health technologies. However, for a variety of reasons, such studies may be included in health technology assessments. There...
5.
Dalziel K, Round A, Garside R, Stein K
Pharmacoeconomics
. 2005 May;
23(5):515-26.
PMID: 15896102
Objective: To evaluate the cost utility of imatinib compared with interferon (IFN)-alpha or hydroxycarbamide (hydroxyurea) for first-line treatment of chronic myeloid leukaemia. Design And Setting: A cost-utility (Markov) model within...
6.
Garside R, Stein K, Wyatt K, Round A
BJOG
. 2005 Jan;
112(1):12-23.
PMID: 15663392
Objective: To compare the effectiveness of two second generation endometrial ablation techniques (microwave and thermal balloon endometrial ablation) with first generation techniques of endometrial ablation to treat heavy menstrual bleeding...
7.
Garside R, Stein K, Wyatt K, Round A, Pitt M
BJOG
. 2004 Sep;
111(10):1103-14.
PMID: 15383113
Objective: To assess the cost effectiveness of the second-generation surgical treatments for heavy menstrual bleeding (microwave and thermal balloon endometrial ablation) compared with existing endometrial ablation techniques (transcervical resection and...